Brivaracetam Tablet, Film Coated
Product Images NDC 73190-075

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 73190-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (074 60)

This is a description of Brivaracetam Tablets from AVKARE, containing 25 mg of brivaracetam per film-coated tablet. The packaging includes 60 tablets and is only available by prescription. The text provides information on the usual dosage and storage conditions. The tablets are manufactured by MSN Pharmaceuticals Inc. in Piscataway, NJ for AVKARE in Pulaski, TN. For full prescribing information, refer to the accompanying package insert.*

FDA Label Image

1 (075 60)

This is a description of a medication called Brivaracetam in the form of film-coated tablets containing 50 mg each. The storage instructions suggest keeping the tablets between 20°C to 25°C (68°F to 77°F). The packaging details include the NDC number 73190-075-60. The tablets are manufactured for AVKARE and come in a bottle with 60 tablets for prescription use only. The text also mentions an accompanying leaflet for full prescribing information.*

FDA Label Image

1 (076 60)

This is a description for a medication called Brivaracetam 75 mg film-coated tablets. Each tablet contains 75 mg of Brivaracetam. The package includes 60 tablets and the medication is only available by prescription. It is recommended to store the tablets at controlled room temperature (68°-77°F). The medication is manufactured by MSN Pharmaceuticals Inc. and distributed by AVKARE in Pulask, TN. A medication guide is provided to each patient for further information.*

FDA Label Image

1 (077 60)

This text provides information about a package insert for brivaracetam tablets containing 100 mg each. It also includes details about storage instructions, manufacturer, quantity (60 tablets), and prescription status. The tablets are manufactured for AvKARE and manufactured by MSN Pharmaceuticals Inc. The storage conditions are specified as 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F).*

FDA Label Image

Brivaracetam-figure-1 (Brivaracetam Figure 1)

This is a chart showing the proportion of patients across different categories (%) and the reduction in seizure frequency from baseline (%) for different dosages of Brivaracetam and Placebo. The percentages shown are for various categories of improvement in seizure frequency for Placebo, Brivaracetam 50 mg/day, Brivaracetam 100 mg/day, and Brivaracetam 200 mg/day.*

FDA Label Image

Brivaracetam-structure (Brivaracetam Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.